EA201290684A1 - Способ получения биологически активного рекомбинантного г-ксф человека - Google Patents
Способ получения биологически активного рекомбинантного г-ксф человекаInfo
- Publication number
- EA201290684A1 EA201290684A1 EA201290684A EA201290684A EA201290684A1 EA 201290684 A1 EA201290684 A1 EA 201290684A1 EA 201290684 A EA201290684 A EA 201290684A EA 201290684 A EA201290684 A EA 201290684A EA 201290684 A1 EA201290684 A1 EA 201290684A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- biologically active
- active recombinant
- csf
- obtaining biologically
- csf human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Предусмотрен способ получения биологически активного рекомбинантного Г-КСФ человека из телец включения, согласно которому процесс солюбилизации и рефолдинга можно осуществлять при температуре окружающей среды, а этап очистки включает хроматографию с обращенными фазами (ОФ), в частности ОФ-ВЭЖХ. Препарат Г-КСФ, полученный таким способом, отличается высокой чистотой и гомогенностью.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10002811 | 2010-03-17 | ||
PCT/EP2011/001331 WO2011113601A1 (en) | 2010-03-17 | 2011-03-17 | Method for obtaining biologically active recombinant human g-csf |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201290684A1 true EA201290684A1 (ru) | 2013-03-29 |
EA022821B1 EA022821B1 (ru) | 2016-03-31 |
Family
ID=42153771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201290684A EA022821B1 (ru) | 2010-03-17 | 2011-03-17 | Способ получения биологически активного рекомбинантного г-ксф человека |
Country Status (16)
Country | Link |
---|---|
US (1) | US8703123B2 (ru) |
EP (1) | EP2547699B1 (ru) |
JP (1) | JP5964757B2 (ru) |
KR (1) | KR101853146B1 (ru) |
CN (1) | CN102892780B (ru) |
AU (1) | AU2011229491B2 (ru) |
BR (1) | BR112012022518A2 (ru) |
CA (1) | CA2789615A1 (ru) |
EA (1) | EA022821B1 (ru) |
ES (1) | ES2611453T3 (ru) |
IL (1) | IL221808B (ru) |
MX (1) | MX2012010661A (ru) |
NZ (1) | NZ601759A (ru) |
PL (1) | PL2547699T3 (ru) |
WO (1) | WO2011113601A1 (ru) |
ZA (1) | ZA201206208B (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102695594A (zh) * | 2010-03-05 | 2012-09-26 | Dic株式会社 | 赋型片及其制造方法 |
HUP1200172A2 (en) * | 2012-03-19 | 2013-10-28 | Richter Gedeon Nyrt | Methods for refolding g-csf from inclusion bodies |
CN103908427B (zh) * | 2013-01-05 | 2014-12-17 | 石药集团百克(山东)生物制药有限公司 | 一种聚乙二醇修饰的rhG-CSF注射液及其制备方法 |
WO2014155365A2 (en) * | 2013-03-29 | 2014-10-02 | Dr.Reddy's Laboratories Limited | Purification method |
EP2978770B1 (en) * | 2013-03-29 | 2019-11-06 | Dr. Reddy's Laboratories Limited | Refolding of proteins |
CN103694339B (zh) * | 2013-12-04 | 2017-10-13 | 珠海联邦制药股份有限公司 | 一种甘精胰岛素前体的复性方法 |
US10457716B2 (en) | 2014-08-06 | 2019-10-29 | University Of Notre Dame Du Lac | Protein folding and methods of using same |
MY184085A (en) * | 2014-12-22 | 2021-03-17 | Ucb Biopharma Sprl | Method of protein manufacture |
JP2016183118A (ja) * | 2015-03-25 | 2016-10-20 | 東ソー株式会社 | 増殖因子前駆体のリフォールディング方法 |
GB201506870D0 (en) * | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
US11629367B2 (en) | 2017-01-16 | 2023-04-18 | Nansha Biologies (HK) Limited | Systems and methods for production of recombinant IL-11 in yeast |
JP7335664B1 (ja) | 2023-04-05 | 2023-08-30 | アポロ興産株式会社 | 包装材の製造方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79124B (ru) | 1982-12-22 | 1984-10-02 | Genentech Inc | |
DE122080T1 (de) | 1983-03-25 | 1985-05-23 | Celltech Ltd., Slough, Berkshire | Verfahren zur herstellung eines proteins. |
US4530787A (en) | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
DE3537708A1 (de) | 1985-10-23 | 1987-04-23 | Boehringer Mannheim Gmbh | Verfahren zur aktivierung von t-pa nach expression in prokaryonten |
DE3611817A1 (de) | 1986-04-08 | 1987-10-15 | Boehringer Mannheim Gmbh | Verfahren zur renaturierung von proteinen |
NZ229098A (en) | 1988-05-13 | 1992-10-28 | Amgen Inc | (bg-csf) bovine granulocyte colony stimulating factor, recombinant methods and pharmaceuticals |
DE3835350A1 (de) | 1988-10-17 | 1990-04-19 | Boehringer Mannheim Gmbh | Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern |
JPH02234679A (ja) * | 1989-03-07 | 1990-09-17 | Sagami Chem Res Center | ヒトラミニンb1鎖ポリペプチド断片及びこれを生産するための発現ベクター |
FR2669646A1 (fr) | 1990-11-23 | 1992-05-29 | Lorraine Laminage | Procede de traitement d'un effluent aqueux issu d'un procede d'electrozingage, ainsi que procede et installation en comportant application. |
DE4105480A1 (de) | 1991-02-21 | 1992-08-27 | Boehringer Mannheim Gmbh | Verbesserte aktivierung von rekombinanten proteinen |
DE60129432T2 (de) * | 2000-05-16 | 2008-04-17 | Bolder Biotechnology, Inc., Louisville | Verfahren zur rückfaltung von proteinen mit freien cysteinresten |
DE102004041639A1 (de) | 2004-08-27 | 2006-03-02 | Bioceuticals Arzneimittel Ag | Verfahren zur Gewinnung von biologisch aktivem humanen G-CSF aus Inclusion Bodies |
DE102005033250A1 (de) | 2005-07-15 | 2007-01-18 | Bioceuticals Arzneimittel Ag | Verfahren zur Reinigung von G-CSF |
GB0605684D0 (en) | 2006-03-21 | 2006-05-03 | Sicor Biotech Uab | Method For Purifying Granulocyte-Colony Stimulating Factor |
WO2008096370A2 (en) | 2007-02-05 | 2008-08-14 | Natco Pharma Limited | An efficient and novel purification method of recombinant hg-csf |
WO2008124406A2 (en) | 2007-04-03 | 2008-10-16 | Neose Technologies, Inc. | Methods of treatment using glycopegylated g-csf |
EP2197919B1 (en) | 2007-08-27 | 2014-04-09 | ratiopharm GmbH | Liquid formulation of g-csf conjugate |
EP2330128B1 (en) * | 2008-08-27 | 2015-12-23 | LSI Medience Corporation | Modified anti-heparin/pf4 complex antibody and hit antibody standard |
-
2011
- 2011-03-17 NZ NZ601759A patent/NZ601759A/xx not_active IP Right Cessation
- 2011-03-17 PL PL11709881T patent/PL2547699T3/pl unknown
- 2011-03-17 ES ES11709881.4T patent/ES2611453T3/es active Active
- 2011-03-17 BR BR112012022518-9A patent/BR112012022518A2/pt not_active IP Right Cessation
- 2011-03-17 AU AU2011229491A patent/AU2011229491B2/en not_active Ceased
- 2011-03-17 EA EA201290684A patent/EA022821B1/ru not_active IP Right Cessation
- 2011-03-17 KR KR1020127027058A patent/KR101853146B1/ko active IP Right Grant
- 2011-03-17 CA CA2789615A patent/CA2789615A1/en not_active Abandoned
- 2011-03-17 EP EP11709881.4A patent/EP2547699B1/en active Active
- 2011-03-17 JP JP2012557447A patent/JP5964757B2/ja not_active Expired - Fee Related
- 2011-03-17 MX MX2012010661A patent/MX2012010661A/es active IP Right Grant
- 2011-03-17 WO PCT/EP2011/001331 patent/WO2011113601A1/en active Application Filing
- 2011-03-17 CN CN201180014299.0A patent/CN102892780B/zh not_active Expired - Fee Related
- 2011-03-17 US US13/634,801 patent/US8703123B2/en not_active Expired - Fee Related
-
2012
- 2012-08-17 ZA ZA2012/06208A patent/ZA201206208B/en unknown
- 2012-09-06 IL IL221808A patent/IL221808B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US8703123B2 (en) | 2014-04-22 |
EP2547699A1 (en) | 2013-01-23 |
CN102892780B (zh) | 2015-07-29 |
BR112012022518A2 (pt) | 2020-10-13 |
KR101853146B1 (ko) | 2018-04-27 |
CN102892780A (zh) | 2013-01-23 |
AU2011229491A1 (en) | 2012-09-06 |
ES2611453T3 (es) | 2017-05-09 |
EP2547699B1 (en) | 2016-10-19 |
ZA201206208B (en) | 2013-05-29 |
WO2011113601A1 (en) | 2011-09-22 |
PL2547699T3 (pl) | 2017-04-28 |
CA2789615A1 (en) | 2011-09-22 |
US20120328560A1 (en) | 2012-12-27 |
KR20130054948A (ko) | 2013-05-27 |
JP2013522252A (ja) | 2013-06-13 |
AU2011229491B2 (en) | 2015-02-05 |
JP5964757B2 (ja) | 2016-08-03 |
EA022821B1 (ru) | 2016-03-31 |
IL221808B (en) | 2018-06-28 |
NZ601759A (en) | 2013-07-26 |
MX2012010661A (es) | 2013-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201290684A1 (ru) | Способ получения биологически активного рекомбинантного г-ксф человека | |
EA201491155A1 (ru) | Новые мутантные про-нрф и их применение для получения бета-нрф | |
MX344815B (es) | Metodo para purificar el factor estimulante de colonias de granulocitos humano a partir de e. coli recombinante. | |
MY172991A (en) | Interleukin-2 muteins for the expansion of t-regulatory cells | |
EA201101208A1 (ru) | Гидрогалогенидный комплекс агомелатина и его получение | |
TR201821186T4 (tr) | Uzun süre etkili büyüme hormonu ve bunun üretim metotları. | |
CY1116987T1 (el) | Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις | |
EA201170962A1 (ru) | Препарат разагилина с отсроченным высвобождением действующего вещества | |
PE20130338A1 (es) | Analogos del glucagon | |
PE20090726A1 (es) | Anticuerpos anti-ige apoptoticos | |
IN2015DN01115A (ru) | ||
EA201270713A1 (ru) | Белки на основе фибронектина с каркасными доменами, которые связывают ил-23 | |
EA201270636A1 (ru) | Способ получения метил-{4,6-диамино-2-[1-(2-фторбензил)-1н-пиразоло[3,4-в]пиридин-3-ил]пиримидин-5-ил}метилкарбамата и его очистки для применения в качестве фармацевтического биологически активного вещества | |
MX2015015188A (es) | Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab. | |
EA201291225A1 (ru) | Улучшенные способы получения сквалена | |
MX2012013232A (es) | Analogos de hormona paratiroidea y usos para los mismos. | |
RU2013135175A (ru) | Фармацевтическая композиция комплекса антитела против дигоксигенина и дигоксигенина, конъюгированного с пептидом | |
PE20170687A1 (es) | Proteinas de enlace a cd127 | |
BR112016010340A2 (pt) | novos métodos para se produzir tert ativa | |
ES2464777T3 (es) | Método de producción de proteína TAT-HOXB4H recombinante para su utilización como estimulante de la hematopoyesis in vivo | |
MX2007010141A (es) | Procesos para la preparacion de intermedios de linezolid. | |
MX2016003705A (es) | Formulacion de un conjugado de hormona del crecimiento humana de accion prolongada. | |
NZ630121A (en) | Process for purifying recombinant plasmodium falciparum circumsporozoite protein | |
PE20170769A1 (es) | Procedimiento novedoso para la purificacion de rhu-gcsf | |
EA201290135A1 (ru) | Способ очистки рекомбинантного эритропоэтина человека (epo), эритропоэтин, очищенный данным способом, и фармацевтические композиции, содержащие такой эритропоэтин |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |